MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ulrich LG et al. | Quality of life and patient preference for sequential versus continuous combined HRT: the UK Kliofem multicenter study experience. UK Continuous Combined HRT Study Investigators. | 1997 | Int J Gynaecol Obstet | pmid:9386211 |
Mc Manus J et al. | The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. | 1997 | Atherosclerosis | pmid:9395275 |
Beier S et al. | The progestational activity of different gestagens used for human contraception in the beagle bitch. | 1979 | Contraception | pmid:94000 |
De Aguilar MA et al. | Current status of injectable hormonal contraception, with special reference to the monthly method. | 1997 | Adv Contracept | pmid:9404550 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction. | 1997 | Contraception | pmid:9408700 | |
Weisberg E et al. | Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring. | 1997 | Contraception | pmid:9408704 |
Shetty G et al. | Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata). | 1997 | Contraception | pmid:9408708 |
Dickey RP et al. | Estrogen potencies of three new low-dose oral contraceptives. | 1976 | Am. J. Obstet. Gynecol. | pmid:941952 |
Andersen RN et al. | Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease. | 1976 | Am. J. Obstet. Gynecol. | pmid:944533 |
Hyder SM et al. | Progestin regulation of vascular endothelial growth factor in human breast cancer cells. | 1998 | Cancer Res. | pmid:9458078 |